About: Evaluation of penicillin G in the prevention of streptococcal septicaemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Evaluation of penicillin G in the prevention of streptococcal septicaemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Evaluation of penicillin G in the prevention of streptococcal septicaemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy
Creator	De Jong, M De Jong, P Kuijper, E Van Der Lelie, J
Source	PMC
abstract	The efficacy of penicillin G was evaluated in the prevention of infections caused by streptococci in patients receiving remission induction or intensive consolidation treatment for acute myeloid leukaemia. Between 1980 and 1988, 29 episodes of streptococcal septicaemia occurred in 139 treatment events. All patients received as prophylaxis regimen ciprofloxacin (n=38) or a combination of polymyxin B with nalidixic acid (n=42) or neomycin (n=59). Six patients died of streptococcal septicaemia despite adequate antibiotic treatment. The high incidence of streptococcal septicaemia lead to the administration of penicillin G in addition to ciprofloxacin as prophylaxis regimen during the 14 days immediately following cytotoxic chemotherapy. Only two episodes of streptococcal septicaemia were documented after addition of penicillin G to the prophylaxis regimen (n=76, p<0.001). Both patients had an uneventful recovery after treatment with vancomycin. Patients receiving penicillin G prophylaxis experienced fever during 17 % of the time and received antimicrobial therapy during 20 % of the time per treatment event compared with 27 % and 32 % respectively of this time in patients receiving no streptococcal prophylaxis (p<0.001). Penicillin G prophylaxis was associated with an increased incidence of fever of unknown origin and more frequent isolation of aerobic gram-negative bacteria in surveillance cultures. Penicillin G in combination with ciprofloxacin proved to be highly successful in preventing infections caused by streptococci and in reducing infection-related mortality and morbidity.
has issue date	1993-01-01(xsd:dateTime)
bibo:doi	10.1007/bf02098462
bibo:pmid	8307043
has license	no-cc
sha1sum (hex)	efead6b95ec284e7b2dd44a45bfc96b4c50bb992
schema:url	https://doi.org/10.1007/bf02098462
resource representing a document's title	Evaluation of penicillin G in the prevention of streptococcal septicaemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy
has PubMed Central identifier	PMC7101765
has PubMed identifier	8307043
schema:publication	Eur J Clin Microbiol Infect Dis
resource representing a document's body	covid:efead6b95ec284e7b2dd44a45bfc96b4c50bb992#body_text
is schema:about of	named entity 'caused' named entity 'aerobic' named entity 'mortality' named entity 'time' named entity 'penicillin G' named entity 'antibiotic' named entity 'efficacy' named entity 'NALIDIXIC ACID' named entity 'FOLLOWING' named entity 'CONSOLIDATION' named entity 'COMPARED' named entity 'FEVER' named entity 'REDUCING' named entity 'MORBIDITY' named entity 'TIME' named entity 'LEAD' named entity 'STREPTOCOCCAL SEPTICAEMIA' named entity 'acute myeloid leukaemia' named entity 'patients' named entity 'streptococcal' named entity 'administration' named entity 'The' named entity 'cytotoxic' named entity 'prophylaxis' named entity 'streptococcal' named entity 'event' named entity 'prophylaxis' named entity 'streptococci' named entity 'Streptococcal' named entity 'prophylaxis' named entity 'antibiotic treatment' named entity 'streptococcal' named entity 'ciprofloxacin' named entity 'prophylaxis' named entity 'vancomycin' named entity 'fever of unknown origin' named entity 'cytotoxic chemotherapy' named entity 'prophylaxis' named entity 'streptococcal' named entity 'streptococci' named entity 'penicillin' named entity '0.01' named entity 'fever' named entity 'ciprofloxacin' named entity 'roxithromycin' named entity 'polymyxin' named entity 'septicaemia' named entity 'infection' named entity 'prophylaxis' named entity 'aerobic' named entity 'penicillin' named entity 'nalidixic acid' named entity 'neutrophil' named entity 'acute leukaemia' named entity 'Streptococcus mitis' named entity 'gram-negative bacteria' named entity 'neutrophil' named entity 'cotrimoxazole' named entity 'vancomycin' named entity 'streptococcal' named entity 'Streptococcus viridans' named entity 'bacterial growth' named entity 'fever' named entity 'fever of unknown origin' named entity 'polymyxin' named entity 'ciprofloxacin' named entity 'penicillin allergy' named entity 'ciprofloxacin' named entity 'penicillin' named entity 'ciprofloxacin' named entity 'fever of unknown origin' named entity 'penicillin' named entity 'ciprofloxacin' named entity 'Erythromycin' named entity 'streptococcal' named entity 'Staphylococcus epidermidis' named entity 'allergy to penicillin' named entity 'erythromycin'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software